YingMeei Tan

429 total citations
10 papers, 328 citations indexed

About

YingMeei Tan is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, YingMeei Tan has authored 10 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in YingMeei Tan's work include Chronic Lymphocytic Leukemia Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related Molecular Pathways (3 papers). YingMeei Tan is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Ubiquitin and proteasome pathways (3 papers) and Cancer-related Molecular Pathways (3 papers). YingMeei Tan collaborates with scholars based in United States, United Kingdom and Belgium. YingMeei Tan's co-authors include John M. Pezzuto, Rong Yu, Charles Spruck, Olle Sangfelt, Dahui Sun, Kathleen Klotz, Diana Cepeda, René Westhovens, John S. Sundy and R. Besuyen and has published in prestigious journals such as Cancer Research, Annals of the Rheumatic Diseases and Nutrients.

In The Last Decade

YingMeei Tan

9 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
YingMeei Tan United States 5 251 67 54 32 30 10 328
Xiaoming Zou United States 10 244 1.0× 65 1.0× 38 0.7× 20 0.6× 13 0.4× 12 345
Yewei Jia China 10 188 0.7× 45 0.7× 54 1.0× 31 1.0× 47 1.6× 19 291
Z. Peter Wang China 14 390 1.6× 121 1.8× 128 2.4× 31 1.0× 14 0.5× 18 524
Lokman Varışlı Türkiye 11 261 1.0× 94 1.4× 100 1.9× 29 0.9× 8 0.3× 28 410
Frédéric Lionneton France 10 191 0.8× 36 0.5× 82 1.5× 21 0.7× 79 2.6× 12 328
Rahul Singh United States 8 188 0.7× 45 0.7× 38 0.7× 20 0.6× 6 0.2× 13 308
Jinyuan Pan China 10 247 1.0× 100 1.5× 144 2.7× 38 1.2× 11 0.4× 12 421
Toshiyuki Sakai Japan 10 341 1.4× 117 1.7× 72 1.3× 23 0.7× 12 0.4× 10 430

Countries citing papers authored by YingMeei Tan

Since Specialization
Citations

This map shows the geographic impact of YingMeei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by YingMeei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites YingMeei Tan more than expected).

Fields of papers citing papers by YingMeei Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by YingMeei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by YingMeei Tan. The network helps show where YingMeei Tan may publish in the future.

Co-authorship network of co-authors of YingMeei Tan

This figure shows the co-authorship network connecting the top 25 collaborators of YingMeei Tan. A scholar is included among the top collaborators of YingMeei Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with YingMeei Tan. YingMeei Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Kavanaugh, Arthur, René Westhovens, Kevin Winthrop, et al.. (2021). Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs. The Journal of Rheumatology. 48(8). 1230–1238. 37 indexed citations
3.
Pérez-García, Luis Fernando, Mihaela Micu, Lien Gheyle, et al.. (2021). POS0526 SEXUAL FUNCTION IN MALE AND FEMALE PATIENTS WITH RHEUMATOID ARTHRITIS: A POST-HOC ANALYSIS OF THE FINCH STUDIES. Annals of the Rheumatic Diseases. 80. 496–497. 1 indexed citations
4.
Besuyen, R., Mark C. Genovese, Kurt de Vlam, et al.. (2020). P372 Effects of filgotinib on anaemia, thrombocytopenia and leukopenia: Phase 3 study results in patients with active rheumatoid arthritis and prior inadequate response/intolerance to biological DMARDs. Journal of Crohn s and Colitis. 14(Supplement_1). S350–S352. 1 indexed citations
5.
Gottenberg, J.E., Roberto Caporali, Grace C. Wright, et al.. (2020). THU0204 A SUBGROUP ANALYSIS OF LOW DISEASE ACTIVITY AND REMISSION FROM PHASE 3 STUDY OF FILGOTINIB IN PATIENTS WITH INADEQUATE RESPONSE TO BIOLOGIC DMARDS. Annals of the Rheumatic Diseases. 79. 326–327. 2 indexed citations
6.
7.
Tan, YingMeei, Dahui Sun, Kathleen Klotz‐Noack, et al.. (2014). PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer. Cancer Research. 74(7). 2006–2014. 18 indexed citations
8.
Tan, YingMeei, Olle Sangfelt, & Charles Spruck. (2008). The Fbxw7/hCdc4 tumor suppressor in human cancer. Cancer Letters. 271(1). 1–12. 78 indexed citations
9.
Klotz, Kathleen, Diana Cepeda, YingMeei Tan, et al.. (2008). SCFFbxw7/hCdc4 targets cyclin E2 for ubiquitin-dependent proteolysis. Experimental Cell Research. 315(11). 1832–1839. 30 indexed citations
10.
Tan, YingMeei, Rong Yu, & John M. Pezzuto. (2003). Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation.. PubMed. 9(7). 2866–75. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoming Zou Breakdown of academic impact, for papers by Yewei Jia Breakdown of academic impact, for papers by Z. Peter Wang Breakdown of academic impact, for papers by Lokman Varışlı Breakdown of academic impact, for papers by Frédéric Lionneton Breakdown of academic impact, for papers by Rahul Singh Breakdown of academic impact, for papers by Jinyuan Pan Breakdown of academic impact, for papers by Toshiyuki Sakai
Rankless by CCL
2026